Michael E. Berens

25.8k total citations · 2 hit papers
197 papers, 12.7k citations indexed

About

Michael E. Berens is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Michael E. Berens has authored 197 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 92 papers in Molecular Biology, 52 papers in Genetics and 46 papers in Cancer Research. Recurrent topics in Michael E. Berens's work include Glioma Diagnosis and Treatment (51 papers), Cellular Mechanics and Interactions (24 papers) and Cell Adhesion Molecules Research (22 papers). Michael E. Berens is often cited by papers focused on Glioma Diagnosis and Treatment (51 papers), Cellular Mechanics and Interactions (24 papers) and Cell Adhesion Molecules Research (22 papers). Michael E. Berens collaborates with scholars based in United States, Germany and Switzerland. Michael E. Berens's co-authors include Nhan L. Tran, Tim Demuth, Alf Giese, Manfred Westphal, Mitsutoshi Nakada, Dominique B. Hoelzinger, Armin Giese, Rolf Bjerkvig, Wendy S. McDonough and Harshil Dhruv and has published in prestigious journals such as Nature, Cell and Journal of Biological Chemistry.

In The Last Decade

Michael E. Berens

186 papers receiving 12.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug-tolerant persister cancer cells are vulnerable to GPX4 inhibition

2017 1.2k citations Harshil Dhruv, Michael E. Berens et al. profile →
Cost of Migration: Invasion of Malignant Gliomas and Implications for Treatment

2003 977 citations Michael E. Berens et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael E. Berens United States	61	6.8k	3.3k	2.7k	2.5k	2.2k	197	12.7k
David Zagzag United States	67	7.8k 1.2×	5.3k 1.6×	5.9k 2.2×	3.4k 1.3×	1.1k 0.5×	258	19.3k
Erwin G. Van Meir United States	70	9.2k 1.4×	4.7k 1.4×	3.5k 1.3×	3.9k 1.5×	1.3k 0.6×	171	16.2k
Gregory J. Riggins United States	55	11.7k 1.7×	5.3k 1.6×	4.8k 1.8×	4.1k 1.6×	1.6k 0.7×	117	18.4k
Hiroyuki Shimada United States	74	8.6k 1.3×	5.3k 1.6×	1.4k 0.5×	3.9k 1.5×	776 0.4×	379	20.8k
Paul S. Mischel United States	79	10.5k 1.6×	5.9k 1.8×	6.0k 2.2×	4.5k 1.8×	1.0k 0.5×	218	19.5k
Christel Herold‐Mende Germany	63	6.3k 0.9×	3.6k 1.1×	5.6k 2.1×	4.3k 1.7×	778 0.4×	313	14.4k
Tom Mikkelsen United States	71	6.4k 0.9×	4.2k 1.3×	9.9k 3.7×	4.1k 1.6×	964 0.4×	258	18.9k
Rameen Beroukhim United States	58	10.0k 1.5×	6.1k 1.8×	1.8k 0.7×	4.1k 1.6×	1.3k 0.6×	155	17.0k
Yiling Lu United States	64	11.6k 1.7×	2.9k 0.9×	792 0.3×	3.5k 1.4×	1.8k 0.8×	209	15.6k
David A. Guertin United States	39	14.8k 2.2×	2.2k 0.6×	1000 0.4×	2.1k 0.8×	2.7k 1.3×	63	21.2k

Countries citing papers authored by Michael E. Berens

Since Specialization

Citations

This map shows the geographic impact of Michael E. Berens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Berens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Berens more than expected).

Fields of papers citing papers by Michael E. Berens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Berens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Berens. The network helps show where Michael E. Berens may publish in the future.

Co-authorship network of co-authors of Michael E. Berens

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Berens. A scholar is included among the top collaborators of Michael E. Berens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Berens. Michael E. Berens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chow, Frances, Michael E. Berens, Sharon Tamir, et al.. (2023). 421 A Phase 1 and Randomized Phase 2 Clinical Trial of Selinexor and Temozolomide in Recurrent Glioblastoma Among Adults: The Product of a Successful Team Science Approach. Journal of Clinical and Translational Science. 7(s1). 126–126.

Cioffi, Gino, Nirav Patil, Kristin Waite, et al.. (2021). Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas. Neuro-Oncology. 24(2). 302–310. 50 indexed citations

Turaga, Soumya M., Daniel J. Silver, Defne Bayık, et al.. (2020). JAM-A functions as a female microglial tumor suppressor in glioblastoma. Neuro-Oncology. 22(11). 1591–1601. 28 indexed citations

Yang, Wei, Nicole M. Warrington, Sara Taylor, et al.. (2019). Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Science Translational Medicine. 11(473). 214 indexed citations

Fons, Nathan R., Ranjini K. Sundaram, G. Breuer, et al.. (2019). PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma. Nature Communications. 10(1). 3790–3790. 51 indexed citations

Panditharatna, Eshini, Lindsay Kilburn, Mariam Aboian, et al.. (2018). Clinically Relevant and Minimally Invasive Tumor Surveillance of Pediatric Diffuse Midline Gliomas Using Patient-Derived Liquid Biopsy. Clinical Cancer Research. 24(23). 5850–5859. 123 indexed citations

Sanai, Nader, Jing Li, Julie L. Boerner, et al.. (2018). Phase 0 Trial of AZD1775 in First-Recurrence Glioblastoma Patients. Clinical Cancer Research. 24(16). 3820–3828. 61 indexed citations

Ensign, Shannon P. Fortin, Alison Roos, Ian T. Mathews, et al.. (2016). SGEF Is Regulated via TWEAK/Fn14/NF-κB Signaling and Promotes Survival by Modulation of the DNA Repair Response to Temozolomide. Molecular Cancer Research. 14(3). 302–312. 14 indexed citations

Tran, Nhan L., Michael E. Berens, Timothy C. Ryken, et al.. (2016). Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma. Molecular Cancer Therapeutics. 15(8). 1799–1808. 5 indexed citations

10.

Assina, Rachid, Tejas Sankar, Nicholas Theodore, et al.. (2008). Activated autologous macrophage implantation in a large-animal model of spinal cord injury. Neurosurgical FOCUS. 25(5). E3–E3. 20 indexed citations

11.

Nowicki, Michal O., Nina Dmitrieva, Andrew M. Stein, et al.. (2008). Lithium inhibits invasion of glioma cells; possible involvement of glycogen synthase kinase-3. Neuro-Oncology. 10(5). 690–699. 100 indexed citations

12.

Salhia, Bodour, Nhan L. Tran, Amanda Chan, et al.. (2008). The Guanine Nucleotide Exchange Factors Trio, Ect2, and Vav3 Mediate the Invasive Behavior of Glioblastoma. American Journal Of Pathology. 173(6). 1828–1838. 148 indexed citations

13.

Tran, Nhan L., Wendy S. McDonough, Benjamin A. Savitch, et al.. (2006). Increased Fibroblast Growth Factor-Inducible 14 Expression Levels Promote Glioma Cell Invasion via Rac1 and Nuclear Factor-κB and Correlate with Poor Patient Outcome. Cancer Research. 66(19). 9535–9542. 163 indexed citations

14.

Nakada, Mitsutoshi, et al.. (2006). Ephrin-B3 Ligand Promotes Glioma Invasion through Activation of Rac1. Cancer Research. 66(17). 8492–8500. 110 indexed citations

15.

Reavie, Linsey B., Tim Demuth, Dominique B. Hoelzinger, et al.. (2006). Glioma invadomics - identification and validation of novel targets for glioma invasion in-vivo. Cancer Research. 66. 434–434. 1 indexed citations

16.

Lipinski, Christopher A., Nhan L. Tran, Jean Kloss, et al.. (2005). The Tyrosine Kinase Pyk2 Promotes Migration and Invasion of Glioma Cells. Neoplasia. 7(5). 435–445. 117 indexed citations

17.

Forman, George, Huan Liu, Edward R. Dougherty, et al.. (2005). Feature selection: We've barely scratched the surface. IEEE Intelligent Systems. 20(6). 74–76. 14 indexed citations

18.

Berens, Michael E., et al.. (2005). Fostering Biological Relevance in Feature Selection for Microarray Data. IEEE Intelligent Systems. 20(6). 71–73. 8 indexed citations

19.

Tran, Nhan L., et al.. (2004). Role of Synaptojanin 2 in Glioma Cell Migration and Invasion. Cancer Research. 64(22). 8271–8275. 131 indexed citations

20.

McDonough, Wendy S., et al.. (1999). Gap junction intercellular communication in gliomas is inversely related to cell motility. International Journal of Developmental Neuroscience. 17(5-6). 601–611. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact